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Abstract
In this paper, the addition of gadolinium is proposed as a useful tool to
enhance the electron spin resonance (ESR) sensitivity of organic compounds
to thermal neutrons. The target of this work is the detection, through the
ESR technique, of the thermal neutron fluence in a mixed field of photons and
neutrons. Gadolinium was chosen because it has a very high capture cross
section to thermal neutrons; its nuclear reaction with thermal neutrons induces
complex inner shell transitions that generate, besides other particles, Auger
electrons, which in turn release their energy in the neighborhood (only several
nanometers) of the place of reaction. Gadolinium was added to two organic
molecules: alanine and ammonium tartrate. The main result obtained was
a greater neutron sensitivity for dosimeters with gadolinium than for those
without gadolinium for both organic molecules used. Since a dosimeter pair
is required to discriminate between the two components of a mixed field, we
studied the response of each dosimeter pair irradiated in a mixed field. Through
a blind test we verified the usefulness of this dosimetric system and we obtained
an estimate of the fluence in the mixed field with a relative uncertainty of 3%,
when the pair composed of an alanine dosimeter and a dosimeter with alanine
and gadolinium is used.
1. Introduction
Neutron applications to tumor radiotherapy are of great clinical and research interest since
the discovery of the neutron by Chadwick in 1962. In fact, fast neutron radiotherapy was
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first used in 1938 in the national laboratories of Lawrence Berkeley (Stone 1940). Nowadays,
neutron radiotherapy is adopted for particular non-operable tumors and in the neoplastic
stage.
Recently, special attention was paid to thermal neutrons since these particles permit us
to selectively hit the treatment volume (Hawthorne 1998, Nigg et al 1997). Neutron capture
therapy (NCT), first proposed by Locher (1936), is based on the ability of marking tumor
cells with molecules containing nuclei with a high cross section for thermal neutrons. After
the injection of these compounds, the exposure to a thermal neutron beam induces nuclear
reactions that produce particles with high linear energy transfer (LET), either heavy charged
particles (alpha, protons and/or light ions) or electrons and/or x-rays with very low energy.
These particles release their energy locally, inside the ‘marked’ tumor cells that are killed,
whereas the dose absorbed by the healthy tissues is minimized.
Nowadays, the most used nucleus for NCT is 10B, because of both its high neutron capture
cross section (about 3800 barn) and the high LET of the secondary particles produced (7Li
and alpha). Recently, the 157Gd nucleus was also utilized in combined therapy (Oyewumi and
Mumper 2003, Culbertson and Jevremovic 2003). This nucleus has a capture cross section
to thermal neutrons (255 000 barn) greater (more than 60 times) than that of 10B. The nuclear
reaction with neutrons induces complex inner shell transitions that involve the emission of
prompt γ photons, of internal conversion electrons and of Auger electrons, together with
soft x-ray and photon emissions. The Auger electrons are the high LET particles which
release energy locally in tumor cells at a distance of a few nanometers from the reaction place
(Salt et al 2004).
The efficacy of the radiotherapy with thermal neutrons (Nigg et al 1997, Alvarez-Estrada
and Calvo 2004) strongly depends on the injection of high concentrations of 10B or 157Gd
inside the tumor cells, and on the choice of the neutron fluence suitable for providing the
prescribed dose. The dosimetry in thermal neutron therapy is complicated by the presence of
a photon component which also releases dose to tissues, often in regions far from the tumor’s
place.
Since any dosimeter for neutrons is also sensitive to photons, neutron dosimetry in mixed
beams is usually performed through two detectors, whose sensitivities to photons and to
neutrons are known (ICRU 1977).
Electron spin resonance (ESR) dosimetry has been studied since the 1960s (Bradshaw
et al 1962, Rotblat and Simmons 1963), and in the last 20 years ESR dosimetry has made great
progress in various fields such as radio-sterilization and radiotherapy. The ESR technique
is based on the detection of free radicals produced by ionizing radiation in organic and/or
inorganic molecules. The most used molecule for ESR dosimetry is alanine which constitutes
an international standard (recognized by the International Atomic Energy Agency). This
amino acid is nowadays widely adopted for photon and electron dosimetry.
Some experimental studies have been realized to investigate the applicability of alanine
dosimeters to high stopping power radiation such as fast neutrons, protons and heavy charged
particles (Hansen et al 1987, Katsumura et al 1985, Simmons 1987).
Along with the NCT development and with the use of thermal neutrons for radiotherapeutic
purposes, ESR dosimetry was applied to measure dose and fluence of these radiation fields.
A limiting feature of alanine for measuring neutron fluence must be underlined, i.e. this
molecule (C3H7O2N) is constituted by nuclei with a relatively low neutron capture cross
section; therefore, the probability of interaction with thermal neutrons is low and so the energy
released inside the dosimeter is small. Consequently, the number of free radicals produced is
very small. Thus, it is very difficult to measure quantitatively the neutron beam properties,
since the ESR signal of irradiated samples is very weak.
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Table 1. Percentage in mass of the elements present in the dosimeters.
Element
Dosimeter H C N O Others ρ (g × cm−3)
Alanine 8.24 43.03 14.79 33.90 0.04 1.04 ± 0.06
B(OH)3–alanine 7.11 27.57 8.77 50.24 6.31 0.88 ± 0.05
Gd2O3–alanine 4.54 24.02 7.39 23.31 40.74 1.35 ± 0.08
Ammonium tartrate 6.98 29.53 14.30 49.15 0.04 1.20 ± 0.07
Gd2O3–ammonium tartrate 3.91 17.27 7.15 30.93 40.74 1.31 ± 0.08
A method for improving the interactions with thermal neutrons is the addition of nuclei
with a high neutron capture cross section that increase the interaction probability with neutrons.
In particular, the sensitivity of alanine to thermal neutrons was increased by the addition of
10B (Bartolotta et al 2004, Galindo and Uren˜a-Nun˜ez 1993), which after nuclear reaction with
thermal neutrons produces heavy charged particles (Li ions and alpha particles) which release
a great amount of energy inside the dosimeter.
In the last few years, substances different from alanine were studied in ESR dosimetry
(Bartolotta et al 1999, Ikeya et al 2000, Lund et al 2002). Among these substances, ammonium
tartrate (C4H12O6N2) is a very promising molecule for the dosimetry of photon and electron
beams (Olsson et al 2000, Bartolotta et al 2001, Yordanov and Gancheva 2004, Marrale et al
2006); however, it also consists of nuclei with a relatively low neutron capture cross section.
Consequently, the addition of nuclei with a higher cross section is needed to increase the
ammonium tartrate dosimeters’ sensitivity to thermal neutrons.
The innovative feature of this work is the choice of gadolinium as additive for maximizing
the interaction probability with thermal neutrons. We analyzed the ESR response of five blends
(alanine, alanine with 10B-boric acid, alanine with gadolinium oxide, ammonium tartrate and
ammonium tartrate with gadolinium oxide) exposed to a mixed field of radiation (neutrons
and photons).
2. Materials and methods
2.1. Dosimeters’ preparation
Solid state pellets for ESR dosimetry were made by using a blend of L-α-alanine (Fluka, Buchs,
Switzerland), ammonium tartrate (Carlo Erba, Italy), gadolinium-oxide (Gd2O3, Aldrich
Chem. Co) and boric acid (BO3H3, Aldrich Chem. Co) enriched with 10B (99%) in known
proportions by mass. The gadolinium oxide is composed of the various gadolinium isotopes
in their natural isotopic composition. In particular, the atomic fractions of the isotopes 157Gd
and 155Gd, which have the highest cross sections for thermal neutron capture (respectively
∼250 000 and ∼75 000 barn), are 0.156 and 0.148, respectively.
The pellets were realized according to a procedure previously optimized (Bartolotta et al
1999) by pressing a blend of 94% of the appropriate active material (either B(OH)3-alanine or
Gd2O3–alanine or pure alanine or Gd2O3–ammonium tartrate or pure ammonium tartrate), 5%
of polyethylene (Polysciences, MW = 700) as binder and 1% of magnesium stearate (Carlo
Erba, Milano, Italy) as lubricant. The pellets of alanine (or ammonium tartrate) with Gd2O3
(or B(OH)3) were realized by pressing a blend in which alanine (or ammonium tartrate) and
Gd2O3 (or B(OH)3) were present in equal proportion by mass (47%). Table 1 reports the
percentages in mass of the elements present in the dosimeters and the mean mass density
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Table 2. Values of neutron fluence and photon dose provided by the irradiation facility (TAPIRO
reactor, ENEA, Casaccia).
Fluence (1012 cm−2) Gamma dose (Gy)
2.40 0.205
3.92 0.325
19.2 1.64
39.2 3.25
values ρ (±1 S.D.) obtained as the ratio of the measured mass to the measured volume of a
representative set of the dosimeter batch.
Pellets of about 4 mm in diameter and 2.2 mm, 1.7 mm, 2.5 mm, 2.5 mm and 1.9 mm
in thickness for ammonium tartrate, Gd2O3–ammonium tartrate, alanine, B(OH)3–alanine and
Gd2O3–alanine, respectively, were obtained.
2.2. γ irradiations
Pellets were irradiated at room temperature in a Perspex phantom with the 1.25 MeV photons
of a 60Co source (Alcyon II, General Electric, France) used for radiotherapy treatments at
the Radiotherapy Department of the Oncology Hospital ‘M.Ascoli’ in Palermo. Irradiations
were performed in a Perspex phantom 30 × 30 × 30 cm3, with a field size of 15 × 15 cm2,
at the water equivalent depth of 5 cm, and with a source–detector distance of 80 cm. The
dose rate at the effective dosimeter location was evaluated with the ENEA (Ente per le nuove
tecnologie, l’energia e l’ambiente, Italy) secondary standard ionization chamber, with an
overall uncertainty of 2% (95% confidence level).
2.3. Thermal neutron irradiations
Thermal neutron irradiations were carried out in the TAPIRO reactor, at the ENEA Casaccia
Center, near Rome. Since TAPIRO is a source of fast neutrons, a suitable removable beam-
shaping assembly (BSA) is needed for obtaining a beam of thermal neutrons. The facility
used is HYTHOR (HYbrid Thermal spectrum sHifter TapirO Reactor) which is based on
a hybrid Pb-CF2-RGGraphite neutron spectrum shifter configuration (Esposito et al 2007).
It provides an eminently thermal neutron beam (about 92% of the total neutron flux) inside
the irradiation cavity with a very low gamma background. More details are given in Esposito
et al (2007).
Cylindrical dosimeter holders (24 mm diameter, 7 mm height) were made with Teflon and
utilized for irradiations. Four dosimeters were placed in suitable small cavities realized inside
the holders, and were irradiated inside the thermal column of the TAPIRO nuclear reactor at
the neutron flux and gamma dose reported in table 2.
Since the neutron flux used consists mainly of thermal neutrons, conventionally in the
following text we will refer to it as a thermal neutron flux.
2.4. ESR measurements
The ESR measurements were taken with a Bruker ECS 106 spectrometer equipped with
a TE102 rectangular cavity and operating in the X band at approximately 9.70 GHz. A
quartz holder and quartz spacers were used to place the dosimeters inside the cavity in the
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position, where the strongest signal was obtained. The first derivative of the ESR absorption
spectrum was recorded at room temperature with the following parameters that maximize the
S/N ratio:
• center field: 348.5 mT
• time constant: 655 ms
• sweep time: 42 s
• modulation amplitude: 1 mT.
Moreover, for the dosimeters containing alanine the additional recording parameters
were
• field sweep: 20 mT,
• microwave power: 4 mW,
whereas for the dosimeters containing ammonium tartrate,
• field sweep: 10 mT
• microwave power: 1.59 mW.
The peak-to-peak signal height hpp of the central line was measured and used as the
dosimetric parameter (Regulla and Deffner 1982, ASTM 1995).
To take into account the dependence of the amplitude of the ESR signal on the orientation
of each pellet inside the resonating cavity (Kojima et al 1995), we read out all samples at four
orientations; each measured peak-to-peak amplitude hpp was divided by the fractional weight
content of alanine or ammonium tartrate in the sample. For each gamma dose and neutron
fluence value, we irradiated three dosimeters and we used the mean value of all the 12 hpp
measurements (four orientation × three dosimeters). The hpp standard deviation was always
within ±3% of the average value.
The dosimeters of Gd2O3–alanine (Brai et al 2007a) and Gd2O3–ammonium tartrate (Brai
et al 2007b) show an ESR signal due to Gd2O3 which is very wide (∼270 mT) and centered in
the g ∼ 2 region field. This background signal is also present in the unirradiated samples and
it does not depend on dose. The contribution of the Gd2O3 signal in the magnetic field range
swept (338.5–358.5 mT for alanine and 343.5–353.5 mT for ammonium tartrate) is linear with
a negative slope. To eliminate this background signal, a linear baseline was subtracted from
each spectrum of Gd2O3–alanine and Gd2O3–ammonium tartrate. hpp for these dosimeters
was measured after this baseline correction.
3. Results and discussion
To perform measurements capable of discriminating the two components (photons and
neutrons) of a mixed radiation field, it is desirable to use a dosimetric system consisting
of a pair of detectors, one sensitive solely to neutrons and the other one solely to photons.
However, the most commonly used dosimeters, such as ionization chambers, Geiger–
Mu¨ller counters, photographic emulsion and thermoluminescent materials, detect both photon
and neutron components without distinguishing one contribution from the other.
If the values of neutron dose and photon dose in a mixed radiation field must be determined,
it is necessary to select an adequate pair of dosimeters with different and known sensitivities to
both radiation beams (ICRU 1977). Furthermore, if the neutron energy spectrum is known, the
neutron kerma can be easily calculated through simple multiplication of the neutron fluence
by the appropriate neutron kerma factor of the irradiated matter; the absorbed dose, in turn,
can be calculated from the kerma value (ICRU 1977). Therefore, we analyzed the response of
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our ESR pellets exposed to a mixed radiation field as a function of the neutron fluence  and
of the gamma dose Dγ through the following equations:{
R
n+γ
A = f nA + f γA Dγ
R
n+γ
B = f nB + f γB Dγ ,
(1)
where Rn+γA is the response of the A dosimeter to the mixed field. The f
γ
A and f nA values
are, respectively, the sensitivity factors to photons and neutrons. In an analogous way, the
quantities with the subscript B refer to the B dosimeter.
The expressions of Dγ and  can be deduced from these equations:

Dγ = f
n
BR
n+γ
A − f nARn+γB
f
γ
A f
n
B − f γB f nA
 = f
γ
A R
n+γ
B − f γB Rn+γA
f
γ
A f
n
B − f γB f nA
.
(2)
To obtain the gamma dose and the neutron fluence we must know, for each dosimeter type,
its sensitivity factor to each mixed field component. Therefore, we performed the calibrations
of the ESR signal versus the gamma dose and the calibration of the ESR signal versus the
neutron fluence.
3.1. Response to 60Co
Calibration to γ photons was carried out in the range 1–50 Gy.
A linear behavior was found for all dosimeter types, and the following function was used
for calibration:
hγ = hγ 0 + f γ Dγ . (3)
The lowest detectable dose (LDD), defined as the dose that produces an ESR signal equal to
the mean value of the zero-dose signal plus three standard deviations (Bartolotta et al 1993),
was also calculated for all blends. The zero-dose signals were obtained from background
measurements of six unirradiated dosimeters for each type in the magnetic field range, wherein
the ESR signal of the radiation-induced free radicals was expected to appear. The LDD values
for each dosimeter were found to be about 3 Gy for alanine and ammonium tartrate, and about
1 Gy for dosimeters with B(OH)3 and Gd2O3 (Brai et al 2007a, 2007b). The reduction of
the LDD in the dosimeters with Gd2O3 can be correlated with the increase of the dosimeter
effective atomic number because of the presence of gadolinium. This increase is found to
enhance the sensitivity to gamma photons and to cause a reduction of the LDD.
We shall use the parameters, such as γ sensitivities (f γ ) and lower detectable dose,
obtained in the above-cited works, to perform the analyses on neutron data.
3.2. Response to thermal neutrons
At this stage we will describe the results obtained after irradiation of the various blends
to the thermal neutron beam. The amplitude of the ESR signal as a function of the thermal
neutron fluence was studied by exposing the dosimeters of each blend to four fluences between
2.40 × 1012 and 3.92 × 1013 cm−2.
The ESR spectra of the solid state dosimeters, realized with alanine, 10B(OH)3–alanine,
Gd2O3–alanine, and exposed to a thermal neutron fluence  = 3.92 × 1012 cm−2, are reported
in figure 1; figure 2 shows the ESR spectra of ammonium tartrate and Gd2O3–ammonium
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Figure 1. ESR spectra of alanine, B(OH)3–alanine and Gd2O3–alanine dosimeters exposed to the
mixed field (thermal neutrons and photons) at the same fluence value ( = 3.92 × 1012 cm−2).
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Figure 2. ESR spectra of ammonium tartrate and Gd2O3–ammonium tartrate dosimeters
exposed to the mixed field (thermal neutrons and photons) at the same fluence value ( = 3.92 ×
1012 cm−2).
tartrate irradiated with the same neutron fluence. The spectra of Gd2O3–alanine and Gd2O3–
ammonium tartrate were obtained by subtraction of the Gd2O3 signal. The qualitative features
of the EPR spectra obtained after irradiation with the mixed photon+neutron field are similar
to those obtained after pure gamma irradiation.
Since the measured total (htot) ESR signal is due to both neutron and photon radiations,
the ESR signal due to the gamma component must be subtracted to take into account only the
neutron contribution. Therefore, the gamma dose measured by the ENEA laboratories was
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Figure 3. Trend of the hn amplitude of the ESR signal of dosimeters of ammonium tartrate and
Gd2O3–ammonium tartrate as a function of thermal neutron fluence. In the figure, the best fit
curves are also reported.
Table 3. Results (sensitivity to γ photons f γ and thermal neutron f n parameters ±1 S.D.) of the
fitting procedure for the three typologies of samples.
Blend Sensitivity to γ photons f γ Sensitivity to neutrons f n
Alanine (A) 0.362 ± 0.004 (3.88 ± 0.04) × 10−13
Ammonium tartrate (AT) 0.403 ± 0.005 (6.75 ± 0.17) × 10−13
B(OH)3–alanine (AB) 0.434 ± 0.010 (49.1 ± 0.9) × 10−13
Gd2O3–alanine (AG) 0.670 ± 0.009 (148.0 ± 0.6) × 10−13
Gd2O3–ammonium tartrate (ATG) 0.724 ± 0.009 (178.0 ± 1.5) × 10−13
converted to the corresponding ESR signal intensity (hγ ), using the 60Co calibration function
of ESR dosimeters, and hγ was subtracted from the total signal, htot. The ‘residual’ ESR signal
(hn = htot − hγ ) is an estimate of the ESR signal attributable to thermal neutrons.
We analyzed the experimental data of the various typologies of dosimeters. A fit with a
linear function was performed:
hn = hn0 + f n, (4)
where  represents the fluence value provided by the irradiation center (which also provided
the fluence uncertainties) and f n is the sensitivity of the blend to the used neutron beam.
In table 3, the values of the gamma sensitivity f γ and the neutron sensitivity f n for each
blend (±1 S.D.) are shown.
As an example figure 3 shows the ‘residual’ ESR signal, hn (with ±1 S.D.), as a function
of the neutron fluence for all blends with ammonium tartrate. In this figure, the best-fit curves
are also shown. After thermal neutron irradiation, the dosimeters with Gd2O3–alanine and
with 10B(OH)3–alanine showed ESR signals were more intense (respectively, about 35 times
and about 12 times) than alanine dosimeters. The dosimeters with Gd2O3–ammonium tartrate
showed an ESR signal, about 26 times stronger in intensity with respect to the ammonium
tartrate dosimeters. Our results show that the addition of gadolinium in both alanine and
ammonium tartrate enhances very much the neutron sensitivity of the pellets. This is due
to the very high thermal neutron capture cross section of the gadolinium and to the Auger
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electrons released in the reaction with the thermal neutrons. Moreover, the sensitivity of
alanine dosimeters with Gd2O3 is greater (about three times) than that of B(OH)3–alanine.
3.3. Dosimetric system realization
When a dosimeter pair (e.g. A and B dosimeters) is exposed to a mixed radiation field, through
the equation system (2), the values of Dγ and  can be obtained once the sensitivity factors to
both photons and neutrons are known.
For the next analysis, we rewrite equation (2) in the following way:

Dγ = fBR
∗n+γ
A − fAR∗n+γB
fB − fA
 = R
∗n+γ
B − R∗n+γA
fB − fA ,
(5)
where R∗n+γA = Rn+γA
/
f
γ
A is the response to the mixed radiation field of the A detector compared
to the sensitivity factor for gamma photons used for calibration and fA = f nA
/
f
γ
A is the ratio of
the neutron sensitivity f nA to the photon sensitivity f
γ
A . The quantities with the subscript B are
related to the B dosimeter. Equation (5) is valid if the detector response is linear with respect
to the gamma dose and to the neutron fluence with a zero intercept. Since the calibration
curve we utilized for both photons and neutrons is a straight line with non-zero intercepts,
we evaluated the quantities R∗n+γA as R
∗n+γ
A =
(
hAtot − hAγ 0 − hAn0
)/
f
γ
A where hAγ 0 and hAn0
indicate the intercepts of the calibration lines for photons and neutrons, respectively, hAtot is
the peak-to-peak amplitude of the ESR signal in the mixed radiation field and f γA is the slope
of the calibration curve to the 60Co photons. An analogous expression was used for the B
detector.
The next step in our study was the determination of the most accurate pair of detectors
for the measurement of thermal neutron fluence. As can be derived from equation (5) through
the uncertainty propagation law, the indeterminates in the fluence and in the dose depend
inversely upon the absolute value of the difference (fB − fA). If this |fB − fA| value is high,
i.e. one dosimeter is more sensitive to photons than to neutrons and the other is more sensitive
to neutrons than to photons, the dosimetric system can distinguish the two components of
the mixed field and the indeterminates are smaller than for low |fB − fA| values. Actually,
for low |fB − fA| values both detector A and detector B have almost the same sensitivity to
neutrons and to photons; therefore fB ≈ fA ≈ 1 and the dosimetric system is not capable of
distinguishing the contribution of each beam to the total signal. Consequently, the uncertainty
under these conditions is greater than that in the first situation. Finally, we expect that the
indeterminates on fluence measurements would be smaller when we use two dosimeters, one
with and the other without additive nuclei, than when the dosimetric pair is constituted by two
dosimeters, both with or without the additive nuclei.
3.4. The blind test
To verify this expectation and, in general, the usefulness of the dosimetric system under
analysis, we performed a blind test. We irradiated at the nuclear reactor TAPIRO four
dosimeters of each blend at unknown values of neutron fluence and photon dose using the
same experimental setup used for the calibration procedure, as discussed in section 2.
The aim of this irradiation was to determine the fluence value through experimental
measurements with a dosimeter pair in the mixed field and by using equation (5) and the
corresponding sensitivity factors to photons and to neutrons.
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Table 4. Values of neutron fluence and photon dose (±1 S.D.) obtained using various dosimeters
pairs. In the table, the values of the sensitivity ratio fA = f nA
/
f
γ
A are also reported.
Dosimeter A fA = f nA
/
f
γ
A Dosimeter B fB = f nB
/
f
γ
B  (1012 cm−2) Dγ (Gy)
A 1.15 AG 22.1 4.81 ± 0.14 1.2 ± 0.4
A 1.15 ATG 26.5 4.7 ± 0.5 1.3 ± 0.7
AT 1.71 AG 22.1 4.76 ± 0.15 2.2 ± 1.2
AT 1.71 ATG 26.5 4.6 ± 0.6 2.4 ± 1.5
As reported in table 4, the best results were obtained when gadolinium was used. The
uncertainties on the fluence and on the dose were calculated by using the uncertainties of the
experimental measurements R∗n+γA and R
∗n+γ
B and of the calibration parameters.
The nominal values of neutron fluence and photon dose, measured at the TAPIRO
laboratories of the ENEA center, Casaccia (Rome), with different measurement systems
(ionization chambers and activation gold foils), are  = (4.80 ± 0.14) × 1012 cm−2 and Dγ
= 0.410 ± 0.012 Gy, respectively.
As can be observed from table 4, all the neutron fluence values obtained through
experimental measurements of the chosen dosimeter pairs are in good agreement with the
nominal value (highest deviation about 4%). Moreover, for the dosimeter pairs of alanine and
Gd2O3–alanine and ammonium tartrate and Gd2O3–alanine, the relative uncertainty is about
3%, well within the limiting value (5%) for application in the radiotherapeutic field.
Regarding the photon dose, the values obtained by using the various detector pairs
(table 4) are all consistent with the zero value. This is observed because the absorbed
photon dose is for all the dosimeter pairs smaller than the lowest detectable dose of at least one
dosimeter of the pair. Consequently, this value cannot be distinguished from the background
signal.
Our results clearly show that the addition of gadolinium significantly increases, and more
than boron, the response of the ESR dosimeters to thermal neutrons.
It is however necessary to underline that alanine and ammonium tartrate dosimeters
with such high amounts of gadolinium oxide lose their tissue equivalence characteristics,
particularly in the low energy range, due to the high atomic number of gadolinium (ZGd = 64).
This can be a serious drawback, since the material used for dosimetry in radiation therapy
should be tissue equivalent, i.e. its atomic composition and density should be close to those of
soft tissue (ICRU 1989). Therefore, under the same irradiation conditions, the photon response
of alanine and ammonium tartrate dosimeters with gadolinium will be different than that of
soft tissue. However, it could be possible to take these differences into account and to correct
the measured dose if the energy spectrum of the photons is well known. It is necessary to
underline that, even though the dosimeter with gadolinium is not tissue equivalent, the neutron
fluence value is determined with high accuracy because the gamma component contributes
much less to the total ESR signal than the neutron component. Also, it should be noted that in
this work we mainly wanted to extend the applicability of ESR dosimetry to characterize the
thermal neutron fluence in the mixed field. New experiments are planned to find the optimized
percentage of gadolinium inside the ESR dosimeter, so that the dosimeter sensitivity to thermal
neutrons can be further improved without significantly modifying its tissue equivalence.
4. Conclusion
We conclude from this study that the employed dosimetric system (a dosimeter pair of alanine
and Gd2O3–alanine and a dosimeter pair of ammonium tartrate and Gd2O3–alanine) is able
Improved ESR neutron dosimetry through gadolinium 5229
to determine the neutron fluence in a mixed field (thermal neutrons and photons) with an
uncertainty of about 3%. This result holds good under irradiation conditions similar to the
calibration ones, that is, when the thermal neutrons are the main component of the neutron
flux.
From calibration curves, we observed that the introduction of Gd in these organic
compounds significantly increases (about a factor of 30) the sensitivity of dosimeters to
neutron radiation. This result is due to the high gadolinium cross section for neutron
capture, that greatly increases the probability of thermal neutrons’ interaction, and also to
the secondary particles and, in particular, the Auger electrons that release their energy entirely
in the dosimeter.
We performed a blind test to analyze the usefulness of the dosimetric system constituted
by two dosimeters, and we obtained that the alanine and Gd–alanine pair and ammonium
tartrate and Gd–alanine furnish a neutron fluence value with a percentage error of 3%, which
is lower than the threshold of 5% for application in radiotherapy.
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